These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25378228)

  • 21. Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
    Troch M; Kiesewetter B; Willenbacher W; Willenbacher E; Zebisch A; Linkesch W; Fridrik M; Müllauer L; Greil R; Raderer M
    Haematologica; 2013 Feb; 98(2):264-8. PubMed ID: 22983582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucosa-associated lymphoid tissue (MALT) lymphoma presenting as subglottic stenosis: single-agent treatment using rituximab.
    Bielinski C; Luu HS; Mau T
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):334-5. PubMed ID: 24334958
    [No Abstract]   [Full Text] [Related]  

  • 23. A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma.
    Chen R; Frankel P; Popplewell L; Siddiqi T; Ruel N; Rotter A; Thomas SH; Mott M; Nathwani N; Htut M; Nademanee A; Forman SJ; Kirschbaum M
    Haematologica; 2015 Mar; 100(3):357-62. PubMed ID: 25596263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
    Jäger G; Neumeister P; Brezinschek R; Hinterleitner T; Fiebiger W; Penz M; Neumann HJ; Mlineritsch B; DeSantis M; Quehenberger F; Chott A; Beham-Schmid C; Höfler G; Linkesch W; Raderer M
    J Clin Oncol; 2002 Sep; 20(18):3872-7. PubMed ID: 12228207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-cell lung cancer arising after chemotherapy for a patient with lymphoma of pulmonary mucosa-associated lymphoid tissue-a case report.
    Nakao M; Oguri T; Maeno K; Kusumoto S; Ota C; Takakuwa O; Uemura T; Ozasa H; Iwashima Y; Miyazaki M; Kutsuna T; Nakamura A; Inagaki H; Sato S; Ueda R
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1711-4. PubMed ID: 19838033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rituximab therapy for systemic manifestations and MALT lymphomas of the parotid gland in Sjögren's disease: preliminary data].
    Logvinenko OA; Vasil'ev VI; Sedyshev SKh; Safonova TN; Rodionova EB; Kokosadze NV; Aleksandrova EN; Cherkasova MV; Radenska-Lopovok SG; Nasonov EL
    Ter Arkh; 2012; 84(12):88-96. PubMed ID: 23479998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MALT lymphoma of the lacrimal gland in the context of systemic lupus erythematosus: complete remission after treatment with rituximab.
    Tektonidou MG
    Lupus; 2010 Sep; 19(10):1243-5. PubMed ID: 20501524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mucosa-associated lymphoid tissue (MALT) lymphoma of the lung treated by surgery and rituximab; report of a case].
    Yoshida C; Tarumi S; Kato A; Nii K; Chang SS; Yokomise H
    Kyobu Geka; 2013 Feb; 66(2):169-72. PubMed ID: 23381369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: report of first case and F-18 FDG PET/CT images.
    Bilici A; Seker M; Ustaalioglu BB; Canpolat N; Salepci T; Gumus M
    J Korean Med Sci; 2011 Apr; 26(4):574-6. PubMed ID: 21468267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren's syndrome: a retrospective clinical study.
    Pollard RP; Pijpe J; Bootsma H; Spijkervet FK; Kluin PM; Roodenburg JL; Kallenberg CG; Vissink A; van Imhoff GW
    J Rheumatol; 2011 Oct; 38(10):2198-208. PubMed ID: 21844152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative outcomes of oncologic therapy in gastric extranodal marginal zone (MALT) lymphoma: analysis of the SEER-Medicare database.
    Olszewski AJ; Castillo JJ
    Ann Oncol; 2013 May; 24(5):1352-9. PubMed ID: 23348804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus.
    Tsujii Y; Nishida T; Kato M; Inoue T; Yamamoto S; Hayashi Y; Akasaka T; Kondo J; Yamada T; Shinzaki S; Iijima H; Tsujii M; Takehara T
    Dis Esophagus; 2013 Apr; 26(3):349-50. PubMed ID: 22882544
    [No Abstract]   [Full Text] [Related]  

  • 34. Second-line 90Yttrium-ibritumomab tiuxetan (Zevalin) in a patient with conjunctival mucosa-associated lymphoid tissue lymphoma refractory to rituximab.
    Oellers P; Savar A; Samaniego F; Pro B; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2012; 28(6):e145-6. PubMed ID: 22820440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary MALT lymphoma revealing AIDS].
    Cortot AB; Cottin V; Issartel B; Meyronet D; Coiffier B; Cordier JF
    Rev Mal Respir; 2006 Sep; 23(4 Pt 1):353-7. PubMed ID: 17127912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy.
    Celiker H; Toker E; Kaygusuz Atagunduz I
    Int Ophthalmol; 2019 Mar; 39(3):687-691. PubMed ID: 29411260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab or rituximab plus chlorambucil for translocation (11;18)-negative gastric mucosa-associated lymphoid tissue lymphoma: a monocentric non-randomized observational study.
    Lévy M; Dupuis J; Charpy C; Martin A; Itti E; Sobhani I; Haioun C; Amiot A
    Leuk Lymphoma; 2022 Nov; 63(11):2597-2603. PubMed ID: 35687839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual cystic presentation of pulmonary nodular amyloidosis associated with MALT-type lymphoma.
    Lantuejoul S; Moulai N; Quetant S; Brichon PY; Brambilla C; Brambilla E; Ferretti GR
    Eur Respir J; 2007 Sep; 30(3):589-92. PubMed ID: 17766635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
    Mino T; Mihara K; Yoshida T; Takihara Y; Ichinohe T
    Blood Cancer J; 2014 Sep; 4(9):e245. PubMed ID: 25215661
    [No Abstract]   [Full Text] [Related]  

  • 40. Pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymph tissue: A case report and literature review.
    Wu Y; Zhao L; Chai Y
    Niger J Clin Pract; 2018 Mar; 21(3):392-394. PubMed ID: 29519992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.